Effects of Preoperative Psychiatric Medication Utilization on Outcomes of Midfoot, Hindfoot, and Ankle Fusions

Research Type: Level 3 - Retrospective cohort study, Case-control study, Meta-analysis of Level 3 studies Introduction/Purpose: Psychiatric medication use is common in surgical patients and has been linked to altered pain perception, immune modulation, and delayed bone healing. However, its impact on foot and ankle fusion outcomes remains unclear. This study investigates the influence of preoperative psychiatric medication use on outcomes following midfoot, hindfoot, and ankle arthrodesis. Methods: This retrospective study utilized the TriNetX database (2005-2025) to compare two cohorts of patients undergoing midfoot, hindfoot, or ankle fusion. Cohort 1 included patients with psychiatric medication use within one year preoperatively, while cohort 2 had no psychiatric medication usage before surgery. Propensity score matching (1:1) accounted for demographics and comorbidities, yielding 5,062 patients per cohort. The psychiatric medication cohort (46.1% female) had a mean age of 53.4 years and BMI of 28.6 kg/m 2 ; the control cohort (45.9% female) had a mean age of 53.6 years and BMI of 29.0 kg/m 2 . Results: At six months, psychiatric medication users had higher risks of fusion reoperation (RR: 2.344; 95% CI: 1.743–3.154), hardware removal (RR: 1.448; CI: 1.175–1.783), and implant-related pain (RR: 1.419; CI: 1.145–1.760), but a lower risk of pseudoarthrosis (RR: 0.616; CI: 0.542–0.701). At two years, these patients remained at higher risk for implant-related pain (RR: 1.667; CI: 1.204–2.308), fusion reoperation (RR: 2.138; CI: 1.379–3.316), and hardware removal (RR: 1.415; CI: 1.033–1.939). A slight increase in deep surgical site infections (RD: 0.002; CI: 0.001–0.004) was observed but is likely not clinically significant. Conclusion: Preoperative psychiatric medication use is associated with increased risks of hardware-related complications and infections following midfoot, hindfoot, or ankle arthrodesis, though a lower rate of nonunion. These findings underscore the importance of recognizing the impact preoperative psychiatric medication usage can have on foot and ankle arthrodesis outcomes. Additional research is needed to further understand these findings.

Authors

Publication Details

Journal
Foot & Ankle Orthopaedics
Published
2025-10-01
DOI
https://doi.org/10.1177/2473011425s00233
Primary Topic
Foot and Ankle Surgery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of Preoperative Psychiatric Medication Utilization on Outcomes of Midfoot, Hindfoot, and Ankle Fusions

John M. Martino, Keneth R. Granados, Jagannath Kandadai, Hana Hashioka et al.
Foot & Ankle Orthopaedics
Foot and Ankle Surgery
article

Effects of Preoperative Psychiatric Medication Utilization on Outcomes of Midfoot, Hindfoot, and Ankle Fusions

John M. Martino, Keneth R. Granados, Jagannath Kandadai, Hana Hashioka, Christopher Gross, Daniel Scott
article en

Abstract

Research Type: Level 3 - Retrospective cohort study, Case-control study, Meta-analysis of Level 3 studies Introduction/Purpose: Psychiatric medication use is common in surgical patients and has been linked to altered pain perception, immune modulation, and delayed bone healing. However, its impact on foot and ankle fusion outcomes remains unclear. This study investigates the influence of preoperative psychiatric medication use on outcomes following midfoot, hindfoot, and ankle arthrodesis. Methods: This retrospective study utilized the TriNetX database (2005-2025) to compare two cohorts of patients undergoing midfoot, hindfoot, or ankle fusion. Cohort 1 included patients with psychiatric medication use within one year preoperatively, while cohort 2 had no psychiatric medication usage before surgery. Propensity score matching (1:1) accounted for demographics and comorbidities, yielding 5,062 patients per cohort. The psychiatric medication cohort (46.1% female) had a mean age of 53.4 years and BMI of 28.6 kg/m 2 ; the control cohort (45.9% female) had a mean age of 53.6 years and BMI of 29.0 kg/m 2 . Results: At six months, psychiatric medication users had higher risks of fusion reoperation (RR: 2.344; 95% CI: 1.743–3.154), hardware removal (RR: 1.448; CI: 1.175–1.783), and implant-related pain (RR: 1.419; CI: 1.145–1.760), but a lower risk of pseudoarthrosis (RR: 0.616; CI: 0.542–0.701). At two years, these patients remained at higher risk for implant-related pain (RR: 1.667; CI: 1.204–2.308), fusion reoperation (RR: 2.138; CI: 1.379–3.316), and hardware removal (RR: 1.415; CI: 1.033–1.939). A slight increase in deep surgical site infections (RD: 0.002; CI: 0.001–0.004) was observed but is likely not clinically significant. Conclusion: Preoperative psychiatric medication use is associated with increased risks of hardware-related complications and infections following midfoot, hindfoot, or ankle arthrodesis, though a lower rate of nonunion. These findings underscore the importance of recognizing the impact preoperative psychiatric medication usage can have on foot and ankle arthrodesis outcomes. Additional research is needed to further understand these findings.

Foot & Ankle OrthopaedicsVol. 10(4)
Good health and well-being
Openalex Percentile: Top 33%
Foot and Ankle Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.